dr. bendell on fda approval of regorafenib in liver cancer
Published 7 years ago • 294 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
0:49
dr. daniele on impact of regorafenib in hcc
-
5:31
practical advice for using regorafenib
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
7:09
global use of regorafenib in hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
1:11
regorafenib vs sorafenib in the treatment of liver cancer
-
9:34
regorafenib in colorectal cancer
-
3:14
when you have decided to prescribe regorafenib
-
1:09
survival benefit confirmed in real-life analysis of second-line regorafenib in hcc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
3:48
clinical experience with regorafenib in hcc
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
11:24
managing toxicities associated with regorafenib
-
7:46
clinical use of regorafenib in mhcc